Victoria Wang

Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy

Lee T. Bacheler, Elizabeth D. Anton, Phil Kudish et al. · Antimicrobial Agents and Chemotherapy · 2000 · 270 citations

Life Sciences, Infectious Diseases, Molecular Genetics +17

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

Tait D. Shanafelt, Victoria Wang, Curtis A. Hanson et al. · Blood · 2022 · 237 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome

Benjamin Frederick Ganzfried, Markus Riester, Benjamin Haibe‐Kains et al. · Database · 2013 · 213 citations · Full text

Medicine, Bioinformatics, Oncology +16

Estimation of sequencing error rates in short reads

Victoria Wang, Natalie J. Blades, Jie Ding et al. · BMC Bioinformatics · 2012 · 81 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib

Victoria Wang, Curtis A. Hanson, Renee C. Tschumper et al. · Blood · 2021 · 35 citations · Full text

Medicine, Oncology, Pharmacology +10